BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 23842598)

  • 1. Emerging evidence on the pathobiology of mucositis.
    Al-Dasooqi N; Sonis ST; Bowen JM; Bateman E; Blijlevens N; Gibson RJ; Logan RM; Nair RG; Stringer AM; Yazbeck R; Elad S; Lalla RV;
    Support Care Cancer; 2013 Nov; 21(11):3233-41. PubMed ID: 23842598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging evidence on the pathobiology of mucositis.
    Al-Dasooqi N; Sonis ST; Bowen JM; Bateman E; Blijlevens N; Gibson RJ; Logan RM; Nair RG; Stringer AM; Yazbeck R; Elad S; Lalla RV;
    Support Care Cancer; 2013 Jul; 21(7):2075-83. PubMed ID: 23604521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy.
    Lalla RV; Bowen J; Barasch A; Elting L; Epstein J; Keefe DM; McGuire DB; Migliorati C; Nicolatou-Galitis O; Peterson DE; Raber-Durlacher JE; Sonis ST; Elad S;
    Cancer; 2014 May; 120(10):1453-61. PubMed ID: 24615748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral mucositis in head and neck cancer: Evidence-based management and review of clinical trial data.
    Blakaj A; Bonomi M; Gamez ME; Blakaj DM
    Oral Oncol; 2019 Aug; 95():29-34. PubMed ID: 31345391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amifostine in the management of radiation-induced and chemo-induced mucositis.
    Bensadoun RJ; Schubert MM; Lalla RV; Keefe D
    Support Care Cancer; 2006 Jun; 14(6):566-72. PubMed ID: 16586122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic review of basic oral care for the management of oral mucositis in cancer patients.
    McGuire DB; Fulton JS; Park J; Brown CG; Correa ME; Eilers J; Elad S; Gibson F; Oberle-Edwards LK; Bowen J; Lalla RV;
    Support Care Cancer; 2013 Nov; 21(11):3165-77. PubMed ID: 24018908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer treatment-induced oral mucositis: a critical review.
    Rodríguez-Caballero A; Torres-Lagares D; Robles-García M; Pachón-Ibáñez J; González-Padilla D; Gutiérrez-Pérez JL
    Int J Oral Maxillofac Surg; 2012 Feb; 41(2):225-38. PubMed ID: 22071451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of oral flora in the development of chemotherapy-induced oral mucositis.
    Stringer AM; Logan RM
    J Oral Pathol Med; 2015 Feb; 44(2):81-7. PubMed ID: 24494824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pathogenesis of mucositis: updated perspectives and emerging targets.
    Bowen J; Al-Dasooqi N; Bossi P; Wardill H; Van Sebille Y; Al-Azri A; Bateman E; Correa ME; Raber-Durlacher J; Kandwal A; Mayo B; Nair RG; Stringer A; Ten Bohmer K; Thorpe D; Lalla RV; Sonis S; Cheng K; Elad S;
    Support Care Cancer; 2019 Oct; 27(10):4023-4033. PubMed ID: 31286231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of laser for the prevention and treatment of oral mucositis induced by radiotherapy and chemotherapy for head and neck cancer].
    Muñoz-Corcuera M; González-Nieto A; López-Pintor Muñoz RM
    Med Clin (Barc); 2014 Aug; 143(4):170-5. PubMed ID: 24216016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic review of miscellaneous agents for the management of oral mucositis in cancer patients.
    Jensen SB; Jarvis V; Zadik Y; Barasch A; Ariyawardana A; Hovan A; Yarom N; Lalla RV; Bowen J; Elad S;
    Support Care Cancer; 2013 Nov; 21(11):3223-32. PubMed ID: 23900593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral mucosal injury caused by cancer therapies: current management and new frontiers in research.
    Jensen SB; Peterson DE
    J Oral Pathol Med; 2014 Feb; 43(2):81-90. PubMed ID: 24261541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucositis: pathobiology and management.
    Villa A; Sonis ST
    Curr Opin Oncol; 2015 May; 27(3):159-64. PubMed ID: 25774860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral mucositis.
    Raber-Durlacher JE; Elad S; Barasch A
    Oral Oncol; 2010 Jun; 46(6):452-6. PubMed ID: 20403721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An update on pharmacotherapies in active development for the management of cancer regimen-associated oral mucositis.
    Villa A; Sonis ST
    Expert Opin Pharmacother; 2020 Apr; 21(5):541-548. PubMed ID: 31990597
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy and safety of rebamipide liquid for chemoradiotherapy-induced oral mucositis in patients with head and neck cancer: a multicenter, randomized, double-blind, placebo-controlled, parallel-group phase II study.
    Yokota T; Ogawa T; Takahashi S; Okami K; Fujii T; Tanaka K; Iwae S; Ota I; Ueda T; Monden N; Matsuura K; Kojima H; Ueda S; Sasaki K; Fujimoto Y; Hasegawa Y; Beppu T; Nishimori H; Hirano S; Naka Y; Matsushima Y; Fujii M; Tahara M
    BMC Cancer; 2017 May; 17(1):314. PubMed ID: 28476132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinctive mucositis and feeding-tube dependency in cetuximab plus radiotherapy for head and neck cancer.
    Yokota T; Onoe T; Ogawa H; Hamauchi S; Iida Y; Kamijo T; Suda T; Yurikusa T; Nishimura T; Yasui H; Onitsuka T
    Jpn J Clin Oncol; 2015 Feb; 45(2):183-8. PubMed ID: 25420692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic review of anti-inflammatory agents for the management of oral mucositis in cancer patients.
    Nicolatou-Galitis O; Sarri T; Bowen J; Di Palma M; Kouloulias VE; Niscola P; Riesenbeck D; Stokman M; Tissing W; Yeoh E; Elad S; Lalla RV;
    Support Care Cancer; 2013 Nov; 21(11):3179-89. PubMed ID: 23702538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients.
    Sonis ST; Elting LS; Keefe D; Peterson DE; Schubert M; Hauer-Jensen M; Bekele BN; Raber-Durlacher J; Donnelly JP; Rubenstein EB; ;
    Cancer; 2004 May; 100(9 Suppl):1995-2025. PubMed ID: 15108222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic review of natural and miscellaneous agents, for the management of oral mucositis in cancer patients and clinical practice guidelines - part 2: honey, herbal compounds, saliva stimulants, probiotics, and miscellaneous agents.
    Yarom N; Hovan A; Bossi P; Ariyawardana A; Jensen SB; Gobbo M; Saca-Hazboun H; Kandwal A; Majorana A; Ottaviani G; Pentenero M; Nasr NM; Rouleau T; Lucas AS; Treister NS; Zur E; Ranna V; Vaddi A; Barasch A; Lalla RV; Cheng KKF; Elad S;
    Support Care Cancer; 2020 May; 28(5):2457-2472. PubMed ID: 32056010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.